India · Delayed Price · Currency is INR Shelter Pharma Statistics
Total Valuation
Shelter Pharma has a market cap or net worth of INR 627.17 million. The enterprise value is 624.39 million.
| Market Cap | 627.17M |
| Enterprise Value | 624.39M |
Important Dates
The next estimated earnings date is Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Sep 23, 2025 |
Share Statistics
Shelter Pharma has 16.84 million shares outstanding. The number of shares has increased by 51.28% in one year.
| Current Share Class | 16.84M |
| Shares Outstanding | 16.84M |
| Shares Change (YoY) | +51.28% |
| Shares Change (QoQ) | -21.95% |
| Owned by Insiders (%) | 39.08% |
| Owned by Institutions (%) | n/a |
| Float | 10.26M |
Valuation Ratios
The trailing PE ratio is 7.22.
| PE Ratio | 7.22 |
| Forward PE | n/a |
| PS Ratio | 0.86 |
| PB Ratio | 0.82 |
| P/TBV Ratio | 0.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 6.92 |
| EV / Sales | 0.85 |
| EV / EBITDA | 4.91 |
| EV / EBIT | 5.06 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.86, with a Debt / Equity ratio of 0.01.
| Current Ratio | 7.86 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | -0.06 |
| Interest Coverage | 197.04 |
Financial Efficiency
Return on equity (ROE) is 15.13% and return on invested capital (ROIC) is 11.93%.
| Return on Equity (ROE) | 15.13% |
| Return on Assets (ROA) | 11.63% |
| Return on Invested Capital (ROIC) | 11.93% |
| Return on Capital Employed (ROCE) | 15.97% |
| Weighted Average Cost of Capital (WACC) | 9.54% |
| Revenue Per Employee | 14.34M |
| Profits Per Employee | 1.77M |
| Employee Count | 51 |
| Asset Turnover | 1.10 |
| Inventory Turnover | 2.98 |
Taxes
In the past 12 months, Shelter Pharma has paid 31.98 million in taxes.
| Income Tax | 31.98M |
| Effective Tax Rate | 26.16% |
Stock Price Statistics
The stock price has decreased by -16.91% in the last 52 weeks. The beta is 0.97, so Shelter Pharma's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -16.91% |
| 50-Day Moving Average | 29.95 |
| 200-Day Moving Average | 33.09 |
| Relative Strength Index (RSI) | 66.35 |
| Average Volume (20 Days) | 31,650 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Shelter Pharma had revenue of INR 731.34 million and earned 90.27 million in profits. Earnings per share was 5.16.
| Revenue | 731.34M |
| Gross Profit | 175.60M |
| Operating Income | 123.35M |
| Pretax Income | 122.25M |
| Net Income | 90.27M |
| EBITDA | 127.25M |
| EBIT | 123.35M |
| Earnings Per Share (EPS) | 5.16 |
Balance Sheet
The company has 10.79 million in cash and 8.01 million in debt, with a net cash position of 2.78 million or 0.17 per share.
| Cash & Cash Equivalents | 10.79M |
| Total Debt | 8.01M |
| Net Cash | 2.78M |
| Net Cash Per Share | 0.17 |
| Equity (Book Value) | 766.32M |
| Book Value Per Share | 46.13 |
| Working Capital | 480.49M |
Cash Flow
In the last 12 months, operating cash flow was -124.80 million and capital expenditures -15.90 million, giving a free cash flow of -140.70 million.
| Operating Cash Flow | -124.80M |
| Capital Expenditures | -15.90M |
| Depreciation & Amortization | 3.90M |
| Net Borrowing | -2.43M |
| Free Cash Flow | -140.70M |
| FCF Per Share | -8.36 |
Margins
Gross margin is 24.01%, with operating and profit margins of 16.87% and 12.34%.
| Gross Margin | 24.01% |
| Operating Margin | 16.87% |
| Pretax Margin | 16.72% |
| Profit Margin | 12.34% |
| EBITDA Margin | 17.40% |
| EBIT Margin | 16.87% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 0.94%.
| Dividend Per Share | 0.35 |
| Dividend Yield | 0.94% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 6.78% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -51.28% |
| Shareholder Yield | -50.34% |
| Earnings Yield | 14.39% |
| FCF Yield | -22.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Shelter Pharma has an Altman Z-Score of 6.81 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.81 |
| Piotroski F-Score | 4 |